We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$552M
AUM Growth
+$56.6M
Cap. Flow
-$262K
Cap. Flow %
-0.05%
Top 10 Hldgs %
37.1%
Holding
134
New
5
Increased
47
Reduced
58
Closed
6

Top Sells

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$10.2M
2
MRK icon
Merck
MRK
+$4.46M
3
ORBK
Orbotech Ltd
ORBK
+$3.74M
4
ABT icon
Abbott
ABT
+$3.39M
5
XOM icon
ExxonMobil
XOM
+$1.79M

Sector Composition

Rank Sector Weight
1 Industrials 25.86%
2 Healthcare 24.55%
3 Technology 16.18%
4 Miscellaneous 8.75%
5 Utilities 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$39.3M 7.12%
574,620
+11,000
+2% +$723K
XOM icon
2
ExxonMobil
XOM
$644B
$32.1M 5.81%
397,110
-23,419
-6% -$1.79M
GVA icon
3
Granite Construction
GVA
$5.44B
$22.4M 4.05%
518,725
+110,091
+27% +$4.9M
GLW icon
4
Corning
GLW
$128B
$21.6M 3.91%
651,882
-4,455
-0.7% -$146K
PFE icon
5
Pfizer
PFE
$159B
$18.6M 3.37%
462,577
-6,107
-1% -$245K
INTC icon
6
Intel
INTC
$473B
$16.7M 3.02%
311,003
-4,285
-1% -$217K
NVS icon
7
Novartis
NVS
$292B
$15.3M 2.77%
177,863
-2,734
-2% -$219K
JNJ icon
8
Johnson & Johnson
JNJ
$646B
$13.4M 2.43%
96,052
-319
-0.3% -$42.7K
BMY icon
9
Bristol-Myers Squibb
BMY
$136B
$12.8M 2.31%
267,957
+31,158
+13% +$1.55M
OGE icon
10
OGE Energy
OGE
$9.45B
$12.7M 2.29%
293,703
-1,590
-0.5% -$65.9K
EEMV icon
11
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.65B
$12.6M 2.28%
212,189
+17,208
+9% +$1.01M
MRK icon
12
Merck
MRK
$366B
$11.7M 2.11%
146,799
-59,669
-29% -$4.46M
MSFT icon
13
Microsoft
MSFT
$3.81T
$11.4M 2.07%
96,769
-1,110
-1% -$121K
LNN icon
14
Lindsay Corp
LNN
$1.16B
$11.1M 2.01%
114,873
-1,047
-0.9% -$95.1K
XRAY icon
15
Dentsply Sirona
XRAY
$2.22B
$11.1M 2.01%
223,675
-1,825
-0.8% -$80.4K
FLS icon
16
Flowserve
FLS
$10.2B
$10.7M 1.93%
235,935
-500
-0.2% -$21.8K
BCE icon
17
BCE
BCE
$21.9B
$10.6M 1.92%
238,494
-651
-0.3% -$28.1K
ABT icon
18
Abbott
ABT
$195B
$10.4M 1.88%
129,922
-45,595
-26% -$3.39M
GSK icon
19
GSK
GSK
$102B
$10.3M 1.87%
197,200
+36,640
+23% +$1.83M
MDU icon
20
MDU Resources
MDU
$4.16B
$10.2M 1.84%
1,034,783
+103,485
+11% +$1M
TT icon
21
Trane Technologies
TT
$98.8B
$9.84M 1.78%
91,116
-1,717
-2% -$174K
LGTY
22
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$9.49M 1.72%
794,051
-1,070
-0.1% -$12K
EVRG icon
23
Evergy
EVRG
$18.6B
$9.12M 1.65%
157,180
-3,028
-2% -$172K
WTS icon
24
Watts Water Technologies
WTS
$12.2B
$8.93M 1.62%
110,442
-2,166
-2% -$165K
HON icon
25
Honeywell
HON
$68.9B
$7.79M 1.41%
51,991
-353
-0.7% -$49.3K

Similar funds

John G. Ullman & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, John G. Ullman & Associates held 134 positions worth $552M, up 11% from $496M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

John G. Ullman & Associates's Q1 2019 filing shows 5 new, 47 increased, 58 reduced and 6 closed positions. Its largest new stake was CarMax: 30,500 shares worth $2.13M. The largest sale was Ciena, an estimated $10.2M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.

  • John G. Ullman & Associates's largest Q1 2019 buy was CarMax: 30,500 shares worth $2.13M.
  • John G. Ullman & Associates added most to Granite Construction in Q1 2019, an estimated $4.9M increase.
  • John G. Ullman & Associates's biggest Q1 2019 reduction was Ciena, cutting an estimated $10.2M.
  • John G. Ullman & Associates fully exited Orbotech Ltd in Q1 2019, selling an estimated $3.74M.
  • John G. Ullman & Associates's ten largest holdings make up 37% of its $552M portfolio in Q1 2019.
  • John G. Ullman & Associates opened 5 new positions and closed 6 in Q1 2019.
  • John G. Ullman & Associates's portfolio value rose 11% quarter-over-quarter to $552M.

Based on John G. Ullman & Associates's 13F filing for Q1 2019, filed 30 Apr 2019.